In this issue of the IADSA Newsflash: China has issued three new technical guidelines related to health food; India is amending its supplement and food regulation; Korea has introduced some changes to its health functional Food Code; Australia has classified sports supplements under the Therapeutic Goods Administration (TGA); and more.
In this issue of the IADSA Newsflash: France alerts consumers about food supplements with claims of curing or preventing COVID-19; Israel notifies WTO about revised limits for polyaromatic hydrocarbons (PAHs) in food supplements; Brazil's new resolution mandating a label when food supplements have a new formulation; Ecuador issues rules for cannabis (hemp seed) supplements; and Peru has established a basic regulation governing health claims applicable to supplement products.
This issue of the IADSA Newsflash covers Australia TGA reclassifies certain sports supplements to be regulated as medicines, South Africa down scheduled CBD to a category of complementary medicine, Korea has updated its functional food code to include ginseng as helpful to bone health and the European Commission (EC) acknowledges the potential to consider traditional use of botanicals in the efficacy assessment of health claims when traditional medicine products exist for botanicals used in foods.
Webinar presenters will address different approaches to sustainability self-assessment, discuss various sustainability standards, and how to create realistic science based targets, and present examples that will help companies of all sizes plan and execute meaningful self-assessments.
Webinar presenters explain ways to ensure your marketing claims for herbal immune support products are substantiated, truthful and not misleading. Industry experts review several methods they’ve used to ensure their dietary supplement product claims are well substantiated, including: randomized, controlled clinical trials on a well-known elderberry product; in vitro testing to support the legitimacy of the product; and the relevance of use and training in substantiating the effectiveness of traditional Chinese herbal formulations.
Since the first week of March, the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have been issuing warning letters alleging that marketers promoted a wide variety of products with claims to prevent, treat, mitigate, diagnose or cure COVID-19.
AHPA has analyzed 135 COVID-19 related warning letters issued by either FDA or FTC or by the agencies jointly between March 6, 2020, and May 11, 2020, and made available in each agency’s coronavirus information center as of May 15, 2020.
2021 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.